Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
112095012	11209501	2	F	2014	20160919	20150622	20160923	EXP		PH-009507513-1506PHL010166	MERCK		76.00	YR		F	Y	0.00000		20160923		CN	PH	PH

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
112095012	11209501	1	PS	JANUVIA	SITAGLIPTIN PHOSPHATE	1	Oral	50 MG, QD			D				21995	50	MG	FILM-COATED TABLET	QD
112095012	11209501	2	SS	JANUVIA	SITAGLIPTIN PHOSPHATE	1	Oral	50 MG, QD			D				21995	50	MG	FILM-COATED TABLET	QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
112095012	11209501	1	Diabetes mellitus

Outcome of event

Reactions reported

Event ID	CASEID	PT
112095012	11209501	Cardiac arrest
112095012	11209501	Cardiac disorder
112095012	11209501	Hepatic cancer
112095012	11209501	Platelet count decreased
112095012	11209501	Product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
112095012	11209501	1	2014	201506	0
112095012	11209501	2	201602		0